Market news

A technical look at the stock

SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.

Tipranks Press Release.

Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.

SANTA CLARA, Calif., September 21, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequenci

Agilent Technologies (A) has an average rating of overweight and mean price target of $176.11, accor

On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workflows. The launch is easy to overlook, but it arrives alongside a strong quarter, and that […]

SANTA CLARA, Calif., September 16, 2026--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.).

SANTA CLARA, Calif., September 16, 2026--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.

SANTA CLARA, Calif., September 10, 2026--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference. The event is scheduled for 10 a.m. BST on Wednesday, Sept. 23, 2026, in London. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website.

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

SANTA CLARA, Calif., September 08, 2026--Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of service as a director. Koh joined Agilent’s board in 2003 and served as independent chair from 2017 until his retirement.

Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Agilent Technologies (A) has an average rating of overweight and mean price target of $176.17, accor

Agilent is rebounding in life science tools with strong recurring revenue and stabilizing margins, but DCF flags overvaluation. Read more on A stock here.

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

SANTA CLARA, Calif., September 01, 2026--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared (FTIR) analysis. Combining robust engineering, superior performance, and intuitive usability, the Cary 635 FTIR provides laboratories with a powerful solution that enhances reliability, boosts productivity, and delivers the versatility required for today’s analytical chal

Agilent Technologies (A) has an average rating of overweight and mean price target of $176.17, accor

Motley Fool Press Release.

Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Agilent Technologies, Inc. (NYSE:A) delivered fiscal third-quarter revenue of $1.88 billion, an increase of 8.1% from a year earlier. Core revenue, which excludes currency movements and recent acquisitions and divestitures, grew 7.3%. The company-defined non-GAAP operating margin of Agilent Technologies, Inc. (NYSE:A) reached 28.3%, expanding 320 basis points year over year. Approximately 110 basis points […]

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

Agilent Technologies (A) is back in focus after raising its fiscal 2026 revenue guidance to a range of $7.49b to $7.51b, alongside fresh fourth quarter projections tied to its latest earnings release. The raised 2026 guidance and stronger recent quarters have come alongside a clear shift in how the market is pricing Agilent Technologies, with a 30 day share price return of 12.20% and a 1 year total shareholder return of 27.21%, which points to building momentum rather than fading...

Earlier this week, Agilent Technologies reported third-quarter fiscal 2026 results showing higher sales and earnings year on year, and raised its full-year 2026 revenue guidance to US$7.49 billion–US$7.51 billion alongside issuing fourth-quarter revenue guidance of US$1.98 billion–US$2.00 billion. Management pointed to strong demand in pharma, China, and applied markets, plus efficiency gains from its Ignite program, as key drivers behind the improved outlook and margin expansion. We’ll now...